Literature DB >> 35831021

Complement is Complimentary in Membranous Nephropathy.

Ralph Kettritz1, Adrian Schreiber2.   

Abstract

Entities:  

Keywords:  complement; membranous nephropathy

Year:  2022        PMID： 35831021      PMCID： PMC9529176          DOI： 10.1681/ASN.2022060633

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   14.978


× No keyword cloud information.
  10 in total

1.  C5a receptor (CD88) blockade protects against MPO-ANCA GN.

Authors:  Hong Xiao; Daniel J Dairaghi; Jay P Powers; Linda S Ertl; Trageen Baumgart; Yu Wang; Lisa C Seitz; Mark E T Penfold; Lin Gan; Peiqi Hu; Bao Lu; Norma P Gerard; Craig Gerard; Thomas J Schall; Juan C Jaen; Ronald J Falk; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

2.  Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.

Authors:  George Haddad; Johan M Lorenzen; Hong Ma; Noortje de Haan; Harald Seeger; Christelle Zaghrini; Simone Brandt; Malte Kölling; Urs Wegmann; Bence Kiss; Gábor Pál; Péter Gál; Rudolf P Wüthrich; Manfred Wuhrer; Laurence H Beck; David J Salant; Gérard Lambeau; Andreas D Kistler
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

3.  Avacopan for the Treatment of ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Peter A Merkel; Thomas J Schall; Pirow Bekker
Journal:  N Engl J Med       Date:  2021-02-18       Impact factor: 91.245

4.  Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy.

Authors:  Shuang Gao; Zhao Cui; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2022-07-01       Impact factor: 14.978

Review 5.  Membranous nephropathy: new pathogenic mechanisms and their clinical implications.

Authors:  Elion Hoxha; Linda Reinhard; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2022-04-28       Impact factor: 42.439

6.  C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.

Authors:  Adrian Schreiber; Hong Xiao; J Charles Jennette; Wolfgang Schneider; Friedrich C Luft; Ralph Kettritz
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

7.  A new role for complement in experimental membranous nephropathy in rats.

Authors:  D J Salant; S Belok; M P Madaio; W G Couser
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

Review 8.  All Things Complement.

Authors:  Joshua M Thurman; Carla M Nester
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

9.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

10.  A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients.

Authors:  Catherine Meyer-Schwesinger; Nicola M Tomas; Silke Dehde; Larissa Seifert; Irm Hermans-Borgmeyer; Thorsten Wiech; Friedrich Koch-Nolte; Tobias B Huber; Gunther Zahner
Journal:  Kidney Int       Date:  2019-11-09       Impact factor: 10.612
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.